MiNK Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from MiNK Therapeutics, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-1.1×Operating cash was negative last year, while some debt falls due within a year.
Higher than 66% of Healthcare companies in United States.
Cash Cushion Ratio
+16%Cash, after subtracting all debt, equals 16% of its market value (net cash).
Higher than 58% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
MiNK Therapeutics, Inc. made a loss over the last year. MiNK Therapeutics, Inc. owes $2.46 for every $1 it owns. MiNK Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossMiNK Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-3.66MiNK Therapeutics, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$51 MThe total market value of all of MiNK Therapeutics, Inc.'s shares at today's price (share price × number of shares), smaller than 73% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeMiNK Therapeutics, Inc.'s net worth is negative ($14 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
2.46×MiNK Therapeutics, Inc. owes $2.46 for every $1 it owns, so it owes more than it owns, higher than 97% of Healthcare companies in United States.
Dividend yield
NoneMiNK Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossMiNK Therapeutics, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashMiNK Therapeutics, Inc. held $8 M more cash than debt (net cash) at Dec 2025.
Questions
How much does MiNK Therapeutics, Inc. owe compared with what it owns?
MiNK Therapeutics, Inc. owes $2.46 for every $1 it owns, so it owes more than it owns, higher than 97% of Healthcare companies in United States.
Does MiNK Therapeutics, Inc. pay a dividend?
No. MiNK Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.